Pharma and BioTech Daily

Pharma and Biotech Daily: Navigating the Competitive Landscape of 2025


Listen Later

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Verdiva has entered the competitive obesity market with a $410 million debut, focusing on next-generation therapies. The company's lead asset is an oral glp-1 receptor agonist that can be dosed weekly, aiming to improve accessibility and affordability. In 2024, the biopharma industry saw a significant increase in first-time VC funding, totaling $7.7 billion over 137 deals. J.P. Morgan predicts a strong year for biopharma in 2025, with an uptick in M&A activity and FDA decisions to watch. The FDA has proposed setting a bar for weight-loss therapies as the obesity space heats up. Lilly has won Medicare coverage for Zepbound in sleep apnea, while Vanda criticizes the FDA's conduct after a drug rejection. Layoffs have affected the gene therapy space, with companies like Resilience and Scribe cutting staff. Overall, the outlook for biopharma in 2025 is cautiously optimistic, with opportunities for innovation and growth.
...more
View all episodesView all episodes
Download on the App Store

Pharma and BioTech DailyBy Pharma and BioTech News

  • 3.6
  • 3.6
  • 3.6
  • 3.6
  • 3.6

3.6

11 ratings


More shows like Pharma and BioTech Daily

View all
WSJ Tech News Briefing by The Wall Street Journal

WSJ Tech News Briefing

1,639 Listeners

NPR News Now by NPR

NPR News Now

14,210 Listeners

WSJ Your Money Briefing by The Wall Street Journal

WSJ Your Money Briefing

1,714 Listeners

Planet Money by NPR

Planet Money

30,652 Listeners

Bloomberg Businessweek by Bloomberg

Bloomberg Businessweek

436 Listeners

WSJ Minute Briefing by The Wall Street Journal

WSJ Minute Briefing

659 Listeners

Equity by TechCrunch, Rebecca Bellan, Kirsten Korosec, Anthony Ha, Max Zeff, Theresa Loconsolo

Equity

338 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

122 Listeners

The Indicator from Planet Money by NPR

The Indicator from Planet Money

9,507 Listeners

The Readout Loud by STAT

The Readout Loud

316 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

5,952 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

30 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

18 Listeners

The Wall Street Skinny by Kristen and Jen

The Wall Street Skinny

195 Listeners

WSJ's Take On the Week by The Wall Street Journal

WSJ's Take On the Week

129 Listeners